Johns Hopkins Investigators Pioneer Novel Treatment for T-Cell Leukemias and Lymphomas

A novel treatment for leukemias and lymphomas that arise from immune system T cells,  developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found to be effective at killing these can

Related Keywords

Virginia ,United States ,American ,America ,Kathy Gabrielson ,Michaels Hwang ,Nina Wagner Johnston ,Nicholas Wyhs ,Nikita Marcou ,Tushar Nichakawade ,Ephraim Fuchs ,Sima Rozati ,Alexanderh Pearlman ,Suman Paul ,Stephanie Glavaris ,Evangeline Watson ,Chetan Bettegowda ,Johns Hopkins ,Seok Lee ,Shibin Zhou ,Bert Vogelstein ,Maximilianf Konig ,Kennethw Kinzler ,Sarahr Dinapoli ,Nickolas Papadopoulos ,Sandrab Gabelli ,Bloomberg Kimmel Institute For Cancer Immunotherapy ,Johns Hopkins University ,National Cancer Institute ,Lustgarten Laboratory ,Johns Hopkins University School Of Medicine ,Leukemia Lymphoma Society Translation Research Program Award ,American Society Of Hematology Scholar Award ,Dk Ludwig Fund For Cancer Research ,Commonwealth Fund ,Lustgarten Foundation For Pancreatic Cancer Research ,Johns Hopkins Kimmel Cancer Center ,Swim Across America Translational Cancer Research Award ,Ludwig Center ,Johns Hopkins University School ,Bum Seok Lee ,Cole Sterling ,Lode Swinnen ,Surojit Sur ,Cancer Research ,Lustgarten Foundation ,Pancreatic Cancer Research ,Kimmel Institute ,Bloomberg Philanthropies ,National Institutes ,American Society ,Hematology Scholar Award ,Swim Across America Translational Cancer Research ,